MAG
XBI icon

Millrace Asset Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Millrace Asset Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.25M Sell
32,847
-2,165
-6% -$213K 3.3% 1
2024
Q2 		$3.25M Buy
+35,012
New +$3.14M 3.15% 1

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Millrace Asset Group's XBI Position: Q3 2024 in Review

Millrace Asset Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 6.2% in Q3 2024, selling an estimated $213K and leaving 32,847 shares worth $3.25M. The position accounts for 3.3% of the portfolio, ranked #1.

Millrace Asset Group first reported a position in XBI in Q2 2024 and has held it in 2 quarters since. The position peaked at $3.25M in Q2 2024. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Millrace Asset Group held 32,847 shares of State Street SPDR S&P Biotech ETF worth $3.25M as of Q3 2024.
  • Millrace Asset Group sold 2,165 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $213K.
  • State Street SPDR S&P Biotech ETF made up 3.3% of Millrace Asset Group's portfolio in Q3 2024, its #1 holding.
  • Millrace Asset Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 2 quarters since.
  • Millrace Asset Group's State Street SPDR S&P Biotech ETF position peaked at $3.25M in Q2 2024.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.